223 related articles for article (PubMed ID: 25925493)
41. Intracellular Delivery of Nanobodies for Imaging of Target Proteins in Live Cells.
Röder R; Helma J; Preiß T; Rädler JO; Leonhardt H; Wagner E
Pharm Res; 2017 Jan; 34(1):161-174. PubMed ID: 27800572
[TBL] [Abstract][Full Text] [Related]
42. Nucleotide-Induced Membrane-Proximal Proteolysis Controls the Substrate Specificity of T Cell Ecto-ADP-Ribosyltransferase ARTC2.2.
Menzel S; Rissiek B; Bannas P; Jakoby T; Miksiewicz M; Schwarz N; Nissen M; Haag F; Tholey A; Koch-Nolte F
J Immunol; 2015 Sep; 195(5):2057-66. PubMed ID: 26209623
[TBL] [Abstract][Full Text] [Related]
43. In vivo molecular imaging of gastric cancer by targeting MG7 antigen with confocal laser endomicroscopy.
Li Z; Zuo XL; Li CQ; Zhou CJ; Liu J; Goetz M; Kiesslich R; Wu KC; Fan DM; Li YQ
Endoscopy; 2013; 45(2):79-85. PubMed ID: 23364839
[TBL] [Abstract][Full Text] [Related]
44. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use.
Lecocq Q; Zeven K; De Vlaeminck Y; Martens S; Massa S; Goyvaerts C; Raes G; Keyaerts M; Breckpot K; Devoogdt N
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569553
[TBL] [Abstract][Full Text] [Related]
45. Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer.
Lwin TM; Turner MA; Nishino H; Amirfakhri S; Hernot S; Hoffman RM; Bouvet M
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625638
[TBL] [Abstract][Full Text] [Related]
46. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis.
Jaffer FA; Vinegoni C; John MC; Aikawa E; Gold HK; Finn AV; Ntziachristos V; Libby P; Weissleder R
Circulation; 2008 Oct; 118(18):1802-9. PubMed ID: 18852366
[TBL] [Abstract][Full Text] [Related]
47. Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells.
Rossotti M; Tabares S; Alfaya L; Leizagoyen C; Moron G; González-Sapienza G
Biochim Biophys Acta; 2015 Jul; 1850(7):1397-404. PubMed ID: 25819371
[TBL] [Abstract][Full Text] [Related]
48. Molecular imaging using Nanobodies: a case study.
Devoogdt N; Xavier C; Hernot S; Vaneycken I; D'Huyvetter M; De Vos J; Massa S; De Baetselier P; Caveliers V; Lahoutte T
Methods Mol Biol; 2012; 911():559-67. PubMed ID: 22886276
[TBL] [Abstract][Full Text] [Related]
49. Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging.
Hebbrecht T; Liu J; Zwaenepoel O; Boddin G; Van Leene C; Decoene K; Madder A; Braeckmans K; Gettemans J
N Biotechnol; 2020 Nov; 59():33-43. PubMed ID: 32659511
[TBL] [Abstract][Full Text] [Related]
50. Non-invasive near-infrared fluorescence imaging of the neutrophil response in a mouse model of transient cerebral ischaemia.
Vaas M; Enzmann G; Perinat T; Siler U; Reichenbach J; Licha K; Kipar A; Rudin M; Engelhardt B; Klohs J
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2833-2847. PubMed ID: 27789786
[TBL] [Abstract][Full Text] [Related]
51. Design and Validation of Site-Specifically Labeled Single-Domain Antibody-Based Tracers for in Vivo Fluorescence Imaging and Image-Guided Surgery.
Declerck NB; Mateusiak L; Hernot S
Methods Mol Biol; 2022; 2446():395-407. PubMed ID: 35157285
[TBL] [Abstract][Full Text] [Related]
52. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
53. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
[TBL] [Abstract][Full Text] [Related]
54. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.
Folli S; Westermann P; Braichotte D; Pèlegrin A; Wagnières G; van den Bergh H; Mach JP
Cancer Res; 1994 May; 54(10):2643-9. PubMed ID: 8168092
[TBL] [Abstract][Full Text] [Related]
55. A novel immuno-gold labeling protocol for nanobody-based detection of HER2 in breast cancer cells using immuno-electron microscopy.
Kijanka M; van Donselaar EG; Müller WH; Dorresteijn B; Popov-Čeleketić D; El Khattabi M; Verrips CT; van Bergen En Henegouwen PMP; Post JA
J Struct Biol; 2017 Jul; 199(1):1-11. PubMed ID: 28552722
[TBL] [Abstract][Full Text] [Related]
56. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
[TBL] [Abstract][Full Text] [Related]
57. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
[TBL] [Abstract][Full Text] [Related]
58. HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.
Altunay B; Morgenroth A; Beheshti M; Vogg A; Wong NCL; Ting HH; Biersack HJ; Stickeler E; Mottaghy FM
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1371-1389. PubMed ID: 33179151
[TBL] [Abstract][Full Text] [Related]
59. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice.
Lisy MR; Goermar A; Thomas C; Pauli J; Resch-Genger U; Kaiser WA; Hilger I
Radiology; 2008 Jun; 247(3):779-87. PubMed ID: 18413884
[TBL] [Abstract][Full Text] [Related]
60. Employing nanobodies for immune landscape profiling by PET imaging in mice.
Teunissen AJP; Abousaway OB; Munitz J; van Leent MMT; Toner YC; Priem B; Senders ML; Pérez-Medina C; Mulder WJM; Rashidian M
STAR Protoc; 2021 Jun; 2(2):100434. PubMed ID: 33899016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
